ArticleBMC urology2017

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.

James A Kuzman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.